Kestra Medical Technologies, Ltd. Common Stock (KMTS)

• Market cap: $790M
• 1 day: -6.79%
• 5 days: -5.64%
• 1 month: -2.90%
• 3 months: -33.01%
• 6 months: -29.58%
• Year to date: -29.58%
• 1 year: -29.58%
• 5 years: -29.58%
• 10 years: -29.58%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.

Employees: 330

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

90.53% more ownership

Funds ownership: 0% [Q4 2024] → 90.53% (+90.53%) [Q1 2025]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $27 76% upside
• Avg. target: $27 76% upside
• High target: $27 76% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Wells Fargo Larry Biegelsen

76% upside $27

Overweight Maintained

17 Jul 2025